Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir
Top Cited Papers
Open Access
- 1 May 2007
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 132 (5), 1767-1777
- https://doi.org/10.1053/j.gastro.2007.02.037
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Hepatitis B and Hepatitis C Viruses in Liver TransplantationTransplantation, 2004
- Past, Present, and Future Hepatitis C TreatmentsSeminars in Liver Disease, 2004
- Diagnosis, management, and treatment of hepatitis C†Hepatology, 2004
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis CAnnals of Internal Medicine, 2004
- Natural history of chronic hepatitis CHepatology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 2001
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998
- Hepatitis C virus: Historical perspective and current conceptFEMS Microbiology Reviews, 1994